Portfolio (Quarterly)
Guide ↗
Walleye Capital LLC
· CIK 0001758720| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1661 | MED | MEDIFAST INC | Consumer Cyclical | 1,452.0 | $15K | — | +1K | +10000.0% | $10.61 | +6.4% |
| 1662 | NEOG PUT | NEOGEN CORP | Healthcare | 1,700.0 | $15K | — | +500.0 | +41.7% | $8.99 | +28.7% |
| 1663 | DXCM | DEXCOM INC | Healthcare | 225.0 | $15K | — | +208.0 | +1223.5% | $67.35 | +33.0% |
| 1664 | INDI PUT | INDIE SEMICONDUCTOR INC | Technology | 3,300.0 | $15K | — | +700.0 | +26.9% | $4.49 | -3.3% |
| 1665 | — | SMURFIT WESTROCK PLC | — | 282.0 | $13K | — | +280.0 | +10000.0% | $46.26 | — |
| 1666 | NMRA | NEUMORA THERAPEUTICS INC. | Healthcare | 7,521.0 | $13K | — | +2K | +39.8% | $1.70 | -3.5% |
| 1667 | NNOX CALL | NANO X IMAGING LTD | Healthcare | 10,700.0 | $12K | — | +700.0 | +7.0% | $1.16 | -23.5% |
| 1668 | BCRX PUT | BIOCRYST PHARMACEUTICALS INC | Healthcare | 1,200.0 | $12K | — | +600.0 | +100.0% | $10.00 | -3.0% |
| 1669 | — | HCM III ACQUISITION CORP | — | 17,025.0 | $11K | — | +2K | +11.1% | $0.65 | — |
| 1670 | — | AMCOR PLC | — | 249.0 | $11K | — | +243.0 | +4050.0% | $43.35 | — |
| 1671 | LVS | LAS VEGAS SANDS CORP | Consumer Cyclical | 174.0 | $8K | — | +108.0 | +163.6% | $46.19 | -1.6% |
| 1672 | GPC | GENUINE PARTS CO | Consumer Cyclical | 65.0 | $8K | — | +55.0 | +550.0% | $117.98 | +11.8% |
| 1673 | DVA | DAVITA INC | Healthcare | 18.0 | $4K | — | +17.0 | +1700.0% | $222.50 | -20.0% |
| 1674 | HTZ | HERTZ GLOBAL HLDGS INC | Industrials | 1,636.0 | $4K | — | +1K | +486.4% | $2.27 | -8.2% |
| 1675 | JACK | JACK IN THE BOX INC | Consumer Cyclical | 101.0 | $2K | — | +88.0 | +676.9% | $15.81 | +5.8% |
| 1676 | AZN | ASTRAZENECA PLC | Healthcare | 6.0 | $1K | — | +5.0 | +500.0% | $189.67 | -15.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
26.7%
Financial Services
20.3%
Industrials
16.5%
Consumer Cyclical
12.2%
Healthcare
9.4%
Communication Services
3.8%
Consumer Defensive
3.4%
Energy
3.3%
Basic Materials
2.4%
Real Estate
1.6%